Document:

Exhibit

Exhibit 10.30

June 16, 2016                       

Dear Maurizio,

Amended and Restated Long Term International Assignment Letter Agreement

We are pleased to confirm the updated details of your Long Term International Assignment to the United States (the “International Assignment”) to reflect your recent promotion to Executive Vice President, Worldwide Sales.  The revised terms of your Long Term International Assignment as outlined below will replace and supersede the terms of your Long Term International Assignment Letter Agreement from 1st April 2016 onwards. The purpose of this letter agreement (“Agreement”) is to vary the terms of your employment with VMware UK Limited (“Home Company”) to reflect the terms and conditions applicable to the International Assignment you and VMware, Inc. (“Host Company”) have agreed upon and which will apply for the duration of your International Assignment.  Any reference in this Agreement to “VMware” shall mean the Host Company and its subsidiaries, including but not limited to the Home Company. The detailed provisions of your compensation, benefits package and Agreement are governed by VMware’s International Long Term Assignment Policy (“International Assignment Policy”), and may be further modified or amended, at the VMware’s discretion.  The continuation of your International Assignment is contingent upon your ability and VMware’s to maintain all necessary visas, work permits, and other mandated host-country requirements.  

During Your Assignment
During your International Assignment, you remain an employee of the Home Company but you will be on a long term employment relationship with the Host Company.  The terms of your UK contract of employment will continue to apply, except if expressed otherwise as set forth in this Agreement and as amended in conjunction with this amended and restated Agreement.  You will remain on your UK payroll.  

Your New Role
Following your promotion to lead the worldwide sales organization, your title is now Executive Vice President, Worldwide Sales.

Local Policies
Where local policies of the Host Company set out benefits which conflict with those in this Agreement, you will be entitled to the benefits set out in this Agreement only, to the extent allowed by local law.   If you have questions regarding which benefits apply to you, you should raise those questions to the Host Company’s human resources group.

There are also local country policies, practices and procedures which govern the behavior of employees in the US.  Unless you are expressly told otherwise in writing, those policies, practices and procedures will apply to your conduct while on International Assignment in the US, along with any global policies of VMware.

Benefits and Compensation
Salary
Your annual salary rate will be GBP 500,000 effective April 1, 2016.

Merit Increases
Any merit increases will be in accordance with VMware’s compensation guidelines in the UK and subject to approval by the Compensation and Corporate Governance Committee of the Board of Directors of the Host Company (the “Committee”).

Bonus
You will be eligible to participate in VMware's Executive Bonus Program as it may be amended from time to time. You will be eligible for an annual target bonus opportunity of 100% of your eligible compensation. Pursuant to the terms and conditions set forth in VMware's Executive Bonus Program, any bonus for which you become eligible will be measured and funded on a semi-annual basis, with the actual payout based on achievement of VMware financial goals and your individual performance, as approved by the Committee. Any bonus payment for your initial period of employment will be prorated based on your actual 

1

start date. VMware reserves the right to modify or discontinue the Executive Bonus Program and/or your bonus opportunity at any time. 
 
Pension
 You remain eligible for UK pension whilst on International Assignment. 

Medical/Dental 
It is intended that you and your eligible dependents receive the same level of medical and dental insurance coverage as you had in the UK.   It is contemplated that you will remain on the existing international plan that you currently participate in.

Equity Awards
With respect to equity awards granted to you in connection with this International Assignment, please be aware that VMware reserves the absolute right in its sole discretion to suspend, modify, cancel or terminate the 2007 Equity and Incentive Plan (the “Plan”) pursuant to which the equity awards are or will be granted at any time without compensation to you. Your participation in the Plan is entirely voluntary and the benefits that are afforded under the Plan (if any) do not form an employment contract with VMware or its subsidiaries.  The equity awards are not part of your salary or other compensation for any purposes.

You are responsible for complying with any applicable legal requirements in connection with your participation in the Plan and for any income taxes and employee social insurance contributions arising from the grant or vesting of your equity awards, the subsequent sale of your shares and the receipt of any dividends or dividend equivalents, if any (regardless of any tax withholding and/or reporting obligations).  Further, we recommend that you seek advice from your personal accountant or tax advisor at your own expense regarding the tax implications of any equity grants made to you.  If your signature is required by applicable laws and regulations in your country in order to receive equity awards, you agree to execute the equity award agreements provided to you by VMware and any additional agreements, documents or instruments that may be required in connection with any equity grant under the Plan. 

International Assignment Benefits
You will be eligible for the following benefits during your International Assignment as outlined in detail in the International Assignment Policy.  
		
	•
	Emergency Leave

		
	•
	Death Overseas

		
	•
	Marital Separation and Divorce

		
	•
	Evacuation

		
	•
	Security

		
	•
	Immigration Assistance

		
	•
	Tax Consultation and Preparation

Tax Equalization and Preparation Program
You will be responsible for complying with any and all applicable income tax regulations in the UK and the US and in any other countries where you are required to pay taxes. 

VMware will provide tax preparation for you for the length of the International Assignment and the year following your repatriation in both the UK and the US.  

It is VMware’s policy to ensure that your UK tax burden will be maintained during the International Assignment period.  The intention of the tax equalization policy is to establish procedures to ensure that income taxes remain a neutral aspect of the International Assignment.  

It is your responsibility to read the Tax Equalization Policy.

At The End of Your International Assignment
If VMware requires that your International Assignment end, it will generally provide you with at least 30 days’ notice of your return to the UK when possible, or such other agreed location.   Employees with international experience are valuable to VMware, so we will make an effort to locate a new role for you before the end of your International Assignment.  However, there is no guarantee that your previous position, or an equivalent or other position, will be available at the completion of your International Assignment.  

2

Please note that all allowances, reimbursements and benefits associated with your International Assignment as outlined above in this Agreement will end at the end of your International Assignment.  However, you will be entitled to receive the following repatriation benefits to assist with your return to the UK or such other country as agreed between the parties:

Repatriation Benefits
At the completion of your International Assignment in the US the following benefits (the “Repatriation Benefits”) will be provided to repatriate you to the UK.  Please refer to the International Assignment Policy for complete details: 

		
	•
	Exit Clearance

		
	•
	Repatriation Briefing

		
	•
	Home Country Departure Assistance

		
	•
	Repatriation Travel

		
	•
	Temporary Living up to 60 days

		
	•
	Repatriation Allowance of USD $7500 

		
	•
	Return Shipment of Household Goods

Termination by you: If you choose to terminate your employment with VMware voluntarily during your International Assignment, VMware will not pay for your return travel to the UK or for return shipment of your household goods, except as required by the terms of your visa or local law or in the event of your own serious illness or that of a close family member.  Furthermore, to the extent permissible by applicable laws, you may be responsible for reimbursing VMware, on a prorated basis, for all expenses associated with your International Assignment that VMware will have incurred until the date of your termination.  VMware may waive its repayment rights under this Agreement in its sole discretion. Any equity awards or special equity awards granted to you in connection with the International Assignment will be treated in accordance with the Plan rules. Any ESPP grants will be treated in accordance with the ESPP plan rules from time to time in force.

Termination by VMware for Cause: If VMware terminates your employment for Cause, as defined in the VMware Executive Retention Plan (the “Retention Plan”) during your International Assignment, your employment relationship with VMware will immediately terminate, to the extent permissible by applicable law.  VMware will not pay for your return travel to the UK or for return shipment of your household goods, except as required by the terms of your visa or local law.  Furthermore, to the extent permissible by applicable laws, you may be responsible for reimbursing VMware, on a prorated basis, for all expenses associated with your International Assignment that VMware will have incurred until the date of your termination.  VMware may waive its repayment rights under this Agreement in its sole discretion. Any equity awards or special equity awards granted to you under this Agreement will be treated in accordance with the Plan rules.  Any ESPP grants will be treated in accordance with the ESPP plan rules from time to time in force.

Termination of Employment
You will also be eligible to participate in VMware’s Change in Control Retention Plan and the Retention Plan (collectively, the “Retention Plans”). It is understood and acknowledged by you and VMware that the waivers of severance benefits that participants in the Retention Plans (the “Waivers”) are required to execute will not apply to the Repatriation Benefits which you will remain eligible to receive should you meet the applicable conditions at the end of this International Assignment but will apply to all other compensation and benefits in connection with any termination of employment with the Host Company and the Home Company set forth in any prior agreements and arrangements between you and the Home Company and you and the Host Company so that you will waive all such other compensation and benefits.  With respect to all other compensation and benefits set forth in any prior agreements and arrangements between you and the Home Company and you and the Host Company, with the exception of benefits potentially available to you under VMware’s Change in Control Retention Plan and the Retention Plan, such other compensation and benefits are hereby superseded by the terms of this Agreement and are of no further force or effect except as such agreements and arrangements may expressly reference this Agreement and the Retention Plans. 

Agreement
It is understood that notwithstanding anything in this Agreement to the contrary, either you or VMware may terminate the employment relationship in accordance with applicable laws. 

Modifications of this Agreement will be made only by an instrument in writing, agreed to and signed by you and countersigned by VMware.  While it is anticipated that the terms of this Agreement will continue during your International Assignment, VMware reserves the right to change any of the terms of this Agreement, including but not limited to, the duration of your International Assignment, and VMware’s guidelines and procedures.  This Agreement, along with the International Assignment Policy, 

3

constitutes the complete agreement of the parties with respect to your International Assignment.  Please acknowledge that you have read, understand and agree with, the terms of this Agreement by signing below.

Standard of Conduct
During your employment with VMware, including during your International Assignment, you agree to: (a) abide by the laws and regulations of the US; and (b) comply with the VMware’s rules and regulations, including not limited to VMware’s Business Conduct Guidelines.

 If so requested by the Host Company, you will be required to sign a Proprietary Information Agreement and Assignment of Inventions Agreement with the Host Company, in compliance with local law, with respect to your activities on behalf of the Host Company during the period of your International Assignment.

Third Party Rights
No term of this Agreement shall be enforceable by a third party pursuant to the Contracts (Rights of Third Parties) Act 1999 save with respect to any and all legal entities within VMware, Inc. which may enforce any term of this Agreement which confers a benefit on such legal entity.  This Agreement may be rescinded or varied by agreement between the parties without the consent of any third party.
Governing Law
Except for any equity awards under the Plan which are subject to the law and jurisdiction of the State of Delaware, this Agreement shall be governed by and construed in accordance with the law of England and Wales.  Each party irrevocably agrees to submit to the exclusive jurisdiction of the courts of England and Wales over any claim or matter arising under or in connection with this Agreement.

Severability
If any term herein is unenforceable in whole or in part, the remainder shall remain enforceable to the extent permitted by law. 

Sincerely,

/s/ Pat Gelsinger

Pat Gelsinger
Chief Executive Officer

I hereby acknowledge that I have read the foregoing Agreement and agree to the terms 

Accepted: /s/ Maurizio Carli                                       June 21, 2016

                   Maurizio Carli                           Date

 

4Form 8-K

 Exhibit 10.6 

DATED 18 SEPTEMBER 2015 

BETWEEN 
 HORIZON PHARMA
PUBLIC LIMITED COMPANY 
 AND 

GOODBODY TRUSTEES LIMITED 

HORIZON PHARMA PUBLIC LIMITED COMPANY 

DIRECTOR SHARE CLOG PROGRAM 

 This TRUST DEED is made on 18 September 2015. 

BETWEEN 
  

	(1)	Horizon Pharma Public Limited Company having its registered office at Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, Ireland, with company registration number 507678 (the “Company”);
and 

  

	(2)	Goodbody Trustees Limited having its registered office at IFSC, 25-28 North Wall Quay, Dublin 1 and established in Ireland under company registration number 118057 (the “Trustee”).

 WHEREAS: 
  

	A.	The Company has granted restricted stock unit awards (“RSUs”) to its non-employee directors under the terms of the Company’s equity incentive plans. 

 

	B.	By entry into the Clog Letter and into this Deed (together being, and hereinafter referred to as, the “Clog Program”) the Company now wishes to impose a restriction on the manner in which the Restricted
Shares (as defined below) acquired by Participants in connection with the vesting and settlement of the RSUs, can be dealt with by the Participants for the duration of the Restricted Period (as defined below). 

 

	C.	As part of the Clog Program the Company wishes to appoint the Trustee as the initial trustee of the Clog Program and the Trustee has consented to act which consent is signified by its execution of this Deed.

  

	D.	This Trust is established by the Company pursuant to a resolution of the compensation committee of the board of the Company passed on 5 August 2015. 

 

	E.	By entry into the Clog Letter, each Participant shall be deemed to have consented to the terms of this Deed and to the appointment of the Trustee. 

 IT IS HEREBY AGREED as follows: 
  

	1	DEFINITIONS 

  

	1.1	In this Agreement: 

  

			
	 Act
	  	the Taxes Consolidation Act, 1997;
		
	 Articles
	  	the Articles of Association of the Company as amended from time to time;
		
	 Acquisition Date
	  	the date on which Restricted Shares are acquired by the Trustee on behalf of a Participant pursuant to the Clog Program being the date or dates the Restricted Shares were issued in settlement of the RSU;
		
	 Clog Letter
	  	means each letter executed by the Company and acknowledged and accepted by each Participant (through the execution of the Acceptance Form contained at Schedule 1 to the Clog Letter) noting specific contractual terms restricting each
Participant’s ability to deal with or realise value in the Restricted Shares during each Participant’s designated Restricted Period;
		
	 EEA Member State
	  	means Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal,
Romania, Slovakia, Slovenia, Spain, Sweden, the UK, Iceland, Liechtenstein and Norway or such other countries that are deemed EEA Member States from time to time;
		
	 Group Company
	  	means the Company and all its Subsidiaries;
		
	 Listing Rules
	  	the rules and codes of any stock exchange under which the Shares may be regulated;
		
	 Market Value
	  	in relation to any Share, the meaning assigned to it by Section 548 of the Act;
		
	 Participant
	  	means a non-employee director of the Company who has elected to participate in the Clog Program including, where the context so permits, the legal personal representatives of a deceased Participant as evidenced to the Trustee by a
grant of probate or letters of administration;
		
	 Restricted Period
	  	means, in relation to each individual Participant, the particular period of time set out in each Participant’s Clog Letter where each Participant is restricted from dealing with or realising value in the Restricted Shares and
such Restricted Shares must remain in this trust;
		
	 Restricted Shares
	  	means the RSU shares which the Participant agrees are subject to the Clog Program, as specified in the Clog Letter
		
	 Subsidiaries
	  	means any subsidiary of the Company which is controlled by the Company, control being construed in accordance with section 432 of the Act;
		
	 Shares
	  	the Ordinary Shares of US$0.0001 each in the capital of the Company issuable or transferable to each Participant under the terms of the RSU, which expression shall include (i) any additional or substituted securities derived fi-om
or distributed in respect of such shares after the date hereof including, without limitation, by virtue of a bonus issue or capitalisation, scrip issue, subdivision, re-organisation, consolidation or other alteration in the capital structure of the
Company or the purchase of shares pursuant to any pre-emption rights and/or the proceeds of any redemption or purchase of such shares; and (ii) such further Ordinary Shares of US$0.0001 each in the capital of the Company that the Trustee holds
subject to the terms of this Deed;
		
	 Taxation
	  	any tax obligation, levies, social security obligations, charges or duties of any kind arising in any jurisdiction under Irish or foreign law;

			
		
	 Taxable Value
	  	the Market Value of a Share on the Acquisition Date on which the Restricted Shares are acquired less any abatement of their value pursuant to the provisions of Section 128D of the Act or otherwise allowed by the Revenue
Commissioners in writing as a result of restrictions in their disposal imposed by the Clog Prop-am;
		
	 Trust
	  	the trust established by this Deed (as amended from time to time);
		
	 Trustee Director
	  	director of the Trustee;
		
	 ‘Trust Period
	  	the period commencing on the establishment of the Trust and ending on its termination in accordance with Clause 18; and
		
	 Trustee
	  	means the trustee that is party to this Deed or any additional or replacement trustee from time to time of the Trust.

  

	1.2	Clause and paragraph headings shall not affect the interpretation of this Deed. 

  

	1.3	A person includes a natural person, corporate or unincorporated body (whether or not having a separate legal personality). 

  

	1.4	A reference to a company shall include any company, corporation or other body corporate, wherever and however incorporated or established. 

 

	1.5	Unless the context otherwise requires, words in the singular shall include the plural and in the plural shall include the singular. 

  

	1.6	Unless the context otherwise requires, a reference to one gender shall include a reference to the other genders. 

  

	1.7	A reference to a statute or statutory provision is a reference to it as amended, extended or re-enacted from time to time. 

  

	1.8	A reference to a statute or statutory provision shall include all subordinate legislation made from time to time under that statute or statutory provision. 

 

	1.9	A reference to writing or written includes fax and email. 

  

	1.10	Any obligation on a party not to do something includes an obligation not to allow that thing to be done. 

  

	1.11	A reference to this Deed or to any other agreement or document referred to in this deed is a reference to this Deed or such other agreement or document as varied or novated (in each case, other than in breach of the
provisions of this Deed) from time to time. 

  

	1.12	References to Clauses are to the Clauses of this Deed. 

  

	1.13	Any words following the terms including, include, in particular, for example or any similar expression shall be construed as illustrative and shall not limit the sense of the words, description, definition, phrase or
term preceding those terms. 

  

	2	ESTABLISHMENT OF THE CLOG PROGRAM 

  

	2.1	The Company established the Clog Program and hereby appoints the Trustee as the Trustee of the Clog Program from the date hereof. 

	3	DECLARATION OF TRUST 

  

	3.1	The Trustee HEREBY DECLARES that all of the Restricted Shares held by it for the purposes of the Clog Program shall be held on trust on behalf of and for the exclusive benefit of the Participants entitled thereto
under the Clog Program subject to and in accordance with the terms of this Deed and the Clog Letter. Furthermore, (a) any Participant who is subject to U.S. federal income tax with respect to the receipt of Shares obtained in connection with an
RSU on the Acquisition Date (a “U.S. Participant”) shall be deemed, for U.S. tax purposes only, to have transferred unencumbered Shares to the Trustee to be held by the Trustee pursuant to the terms of this Deed and the applicable
Clog Letter, (b) this Deed shall be deemed to have created a separate trust with respect to each such U.S. Participant and (c) each such separate trust shall be treated as a “grantor trust” within the meaning of Section 671
of the Internal Revenue Code of 1986, as amended with the U.S. Participant as the deemed owner of the Restricted Shares held in such separate trust for the benefit of the U.S. Participant. 

 

	3.2	The Trustee shall stand registered as the legal owner of the Restricted Shares in the Register of Members of the Company during the Restricted Period. 

 

	3.3	The Trust shall be operated and administered in accordance with this Deed and for the Trust Period. 

  

	3.4	The Company has no ownership or beneficial interest in the Restricted Shares or the Trust, and neither the Restricted Shares nor the Trust assets are subject to the claims of the Company’s creditors under any
circumstances. The Restricted Shares may only be delivered by the Trustee to the Participant or otherwise in accordance with the Participant’s instructions as further provided herein, and shall not be delivered to the Company or any creditor
thereof. 

  

	4	TRUSTEE’S DUTIES RELATING TO THE CLOG PROGRAM 

  

	4.1	The Trustee shall hold Restricted Shares upon trust in respect of the Participants in accordance with the terms of the Clog Program. 

 

	4.2	On the vesting of an award under the RSU where some or all of the Shares subject to that award have been designated as Restricted Shares, the Company shall allot and issue, or transfer, the Restricted Shares issuable or
transferable to the relevant Participant in connection therewith in the name of (or in accordance with the directions of) the Trustee and write up the Company’s Register of Members accordingly. 

 

	4.3	As soon as may be practicable after any Restricted Shares have been acquired by the Trustee on behalf of a Participant in accordance with Clause 4.2 the Trustee shall give the Participant notice in writing of the
acquisition specifying the number and description of the Restricted Shares so acquired and stating their Taxable Value and the end of the relevant Restricted Period. 

 

	4.4	During the Restricted Period, the Trustee shall not permit the Restricted Shares held by it on behalf of a Participant to be assigned, charged, pledged as security for a loan or other debt, transferred or otherwise
disposed of (whether by transfer to the Participant or otherwise) otherwise than pursuant to the exceptions to the Restricted Period as noted in the Clog Letter and in accordance with Section 128D of the Act. At the expiry of the Restricted
Period, the Trustee shall have the power to dispose of or transfer the Restricted Shares at the sole direction of the Participant. It shall be the responsibility of the Participant to ensure that such sale or transfer is made in accordance with
applicable laws or regulations. 

  

	4.5	The Trustee acknowledges that all cash dividends, cash distributions and other monies accruing to and received by the Trustee pursuant to or in respect of the Restricted Shares shall be the property of and belong to the
Participants and shall pay over to the Participants any money or money’s worth received by the Trustee on or after the relevant Acquisition Date by reference to any Restricted Shares in respect of which the Participant holds the beneficial
interest except: 

  

	 	4.5.1	where the Participant has directed that the proceeds of any disposal of rights arising under a rights issue be re-invested in the exercise of other rights accruing to the Participant’s Restricted Shares;

  

	 	4.5.2	where the money’s worth consists of new shares arising from a company reconstruction or rights issue 

PROVIDED THAT (a) such direction set forth in Clause 4.5.1 does not breach the requirements of Section 128D of the Act, and
(b) the Trustee may deduct from such monies the amount of any brokerage fees, stamp duty, bankers’ charges or other vouched costs and expenses incurred by them in connection with the realisation of any such money or money’s worth.

  

	4.6	Subject to Clauses 4.4 and 6.2, the Trustee shall deal with any rights conferred in respect of any Restricted Shares held on behalf of the Participant to be allotted other shares, securities or rights of any description
as the Participant shall direct. 

	4.7	The Trustee shall maintain such records as may be necessary to enable the Trustee to carry out its obligations under the Act and this Agreement. The Trustee shall inform each Participant in writing of any facts known to
the Trustee which the Trustee or the Participant reasonably considers to be relevant to determining the liability (if any) of that Participant to any Irish taxes as a result of the Participant’s participation in the Clog Program.

  

	4.8	Subject to Clause 4.4 no Restricted Shares shall be transferred directly or indirectly to or for the benefit of a Participant unless the Trustee is satisfied that such arrangements have been made by or on behalf of the
Participant as the Trustee or the Company may from time to time reasonably require (with notice to the Participant ) to ensure that any liability to taxation whatsoever and howsoever arising will be discharged or reimbursed to the Trustee and/or (as
the case may be) the Company which has or will have to account for such liability. 

  

	4.9	The Trustee shall, notwithstanding anything to the contrary in this Deed, act in accordance with any obligations imposed on it as a shareholder under the Articles for the time being. 

 

	4.10	In the event of a Participant’s death, the Trustee shall transfer the relevant Participant’s Restricted Shares (i) to that Participant’s personal representatives upon production of evidence
satisfactory to the Trustee of the appointment of the personal representatives as such or (ii) to such other person or entity as directed by the Participant prior to the Participant’s death and in accordance with a procedure adopted by the
Trustee for such purpose. 

  

	5	POWERS OF TRUSTEE 

  

	5.1	In addition to the powers vested in the Trustee by the provisions of Clog Program and otherwise by law or statute, the Trustee shall have all additional powers necessary to perform its functions and duties as set out in
the Clog Program such powers only to be used in accordance with the purpose for which they were granted and in accordance with the Clog Program and in particular the following powers: 

 

	 	(a)	Power to place any trust monies on deposit or in a current account with any bank, building society or other licensed deposit taking institution carrying on business in Ireland, Europe or the US whether or not associated
in business with the Trustee and the Trustee shall not be obliged to earn interest in respect of such money. 

  

	 	(b)	Power to enter into any agreement with any party for the sale or other disposition or for the purchase of Restricted Shares to the extent that this is provided for by the Clog Program. 

 

	 	(c)	Power to manage and deal with the Restricted Shares and exercise the rights incident to those Restricted Shares. 

  

	 	(d)	Power to provide for any Restricted Shares to be registered in the name of an appointed nominee or custodian provided that such Restricted Shares shall be registered in a designated account. Such registration shall not
divest the Trustee of its responsibilities under the Clog Program. 

  

	 	(e)	Power from time to time to appoint such secretarial or executive officers or staff as the Trustee considers desirable, on such terms as the Trustee thinks fit, for the proper administration and management of the Trust.

  

	 	(f)	Subject to the prior consent of the Company, such consent not to be unreasonably withheld or delayed, power to delegate from time to time any business and the exercise of any of the trusts, powers, discretions and
duties imposed on the Trustee under the Trust to any person (whether being a Trustee or not) or persons or fluctuating body of persons, and such delegation may be made upon such terms and conditions, including power to sub-delegate, and subject to
such regulations as the Trustee may think fit, and the Trustee will not be bound to supervise the proceedings of any such delegate or sub-delegate, but notwithstanding any such delegation the Trustee will be and remain responsible for the
administration of the Trust and for the acts of such persons to whom the Trustee may delegate duties in connection with the Trust, subject to Clause 15 hereof. 

  

	 	(g)	Power to employ and pay for the service of such registrars, solicitors or other professional or business advisers or agents generally as they consider desirable to advise on or transact or concur in transacting any
business to be done for the proper administration and management of the Trust or otherwise in connection therewith. 

  

	5.2	The Trustee may at any time revoke any delegation or arrangement under this Clause 5 and/or require any trust property held by another person to be returned to the Trustee. 

 

	5.3	Any costs, charges or expenses incurred by the Trustee in accordance with this Clause 5 will form part of the costs, charges and expenses necessarily incurred by the Trustee in the execution of the Trust.

	6	DEALING WITH THE RESTRICTED SHARES 

  

	6.1	Save as otherwise provided for by the Clog Program, the Trustee shall not sell or otherwise dispose of the Restricted Shares. 

  

	6.2	The Participant shall have the right to vote the Restricted Shares. The Trustee shall obey any voting instructions and any other lawful directions given by a Participant in accordance with the Clog Program in relation
to his/her Restricted Shares and any rights and income relating to those Restricted Shares. In the absence of any such direction, or provision by the Clog Program, the Trustee shall not vote in respect of the Restricted Shares unless the Trustee
determines that it shall seek voting directions from the Participant where circulars or other shareholder documents contain information that may have a material impact on a Participant’s Restricted Shares in which case the Trustee may take such
action as it may consider reasonable. 

  

	6.3	Save in cases of fraud, wilful misconduct or gross negligence by the Trustee, any Trustee Director or any of their respective agents or employees, neither the Trustee nor any Trustee Director shall be liable for:

  

	 	(a)	any loss or damage which may happen to the Restricted Shares as a result of an act or omission of the Trustee or authorised by the Trustee Directors; 

 

	 	(b)	any act or omission of any agent employed by the Trustee, even where such employment was not strictly necessary or expedient; or 

  

	 	(c)	any mistake or omission made in good faith by the Trustee or any Trustee Director. 

  

	6.4	The Trustee will on request from a Participant provide the Participant with copies of circulars and other documents sent to holders of Restricted Shares which the Trustee has received and otherwise shall have discretion
whether to send shareholder notices and circulars to Participants. 

  

	7	RIGHTS ISSUES 

  

	7.1	In the event of the Company making an offer or invitation conferring any rights upon its members to acquire against payment additional securities or rights of any description in the Company, the Trustee shall seek each
Participant’s directions and shall act on any instructions received within the deadline for responses set by the Trustee provided such instructions do not breach the requirements of Section 128D of the Act and the Trustee will not be
required to exercise any such rights except to the extent that they have been provided with the full amount payable on such exercise either by the relevant Participant or (with his authority) out of the net proceeds of the sale, nil paid, of another
part of the rights attributable to that Participant’s Restricted Shares. 

  

	7.2	If the Trustee receives any such offer or invitation as is referred to in Clause 7.1, the Trustee shall notify each Participant of the rights which are attributable to his Restricted Shares. In the event that the
Trustee receives no directions in accordance with Clause 7.1 in respect of such notification, the Trustee may at it’s discretion determine that: 

  

	 	7.2.1.	the Trustee will take no action in respect of the rights; or 

  

	 	7.2.2.	the Trustee will sell enough of the rights to enable the subscription of the balance of such rights, 

provided that the Trustee’s actions shall not breach Section 128D of the Act. 

 

	8	CAPITALISATION ISSUES 

 In the event of the Company allotting any new securities by way
of capitalisation to the Trustee in respect of a Participant’s Restricted Shares, such new securities will, subject to the Act, form part of the Participant’s Restricted Shares and will be deemed to have been acquired at the same time as,
and will be held by the Trustee on the same terms as, the Restricted Shares to which such new securities relate. 
  

	9	TAKEOVERS AND OTHER TRANSACTIONS AFFECTING SHARES 

  

	9.1	In the event that: 

  

	 	9.1.1	an offer is made to acquire a Participant’s Restricted Shares (in this sub-clause referred to as original shares) in circumstances such that acceptance thereof will result in a new holding (as defined in section
584 of the Act) being equated with such original shares for the purposes of capital gains tax; 

	 	9.1.2.	an offer is made to acquire a Participant’s Restricted Shares as part of a general offer made to holders of shares of the same class as the Restricted Shares or of shares in the Company for a cash consideration,
with or without other assets, and is also made in the first instance on a condition such that, if it is satisfied, the person making the offer will have control of the Company (within the meaning of section 432 of the Act); or 

 

	 	9.1.3.	a transaction is proposed which affects a Participant’s Restricted Shares or such of them as may be of a particular class and such transaction would be entered into pursuant to a compromise, arrangement or scheme
applicable to or affecting all the shares of the Company or, as the case may be, all the Shares of the class in question; 

then, notwithstanding any other provision of the Clog Program, the Trustee may, at the direction of the relevant Participant, accept such offer
or, as the case may be, agree to such compromise arrangement or plan in respect of his Restricted Shares. 
  

	9.2	In the event that any offer is made or compromise, arrangement or plan proposed affecting any of a Participant’s Restricted Shares which does not fall within Clause 9.1, then the relevant Participant may only
direct the Trustee to accept or agree thereto to the extent that implementation thereof would not result in a breach of Clause 4.4 or of Section 128D of the Act. 

 

	9.3	The Trustee will promptly take all reasonable steps using information supplied by the Company to notify each Participant of the principal terms of any offer, compromise or plan falling within this Clause 9 and in the
absence of any direction from a Participant concerning how the Trustee should act thereon in respect of that Participant’s Restricted Shares the Trustee shall not take any action in respect thereof. 

 

	9.4	In any of the following events: 

  

	 	9.4.1.	if the Company ceases to carry on business and another body corporate, person or firm (whether in contemplation of or after such cessation of business) enters into an agreement with the Trustee to perform the
obligations of the Company under the Trust Deed; 

  

	 	9.4.2.	if the business or a part of the business of the Company is acquired by or vested in any other body corporate, person or firm and such other body corporate, person or firm enters into an agreement with the Trustee or is
bound by virtue of or pursuant to any statutory provision or instrument made thereunder or any order of a Court or otherwise to perform the said obligations; 

  

	 	9.4.3.	if the Company is dissolved by virtue of or pursuant to any statutory provision or any order of the Court made thereunder or otherwise, and another body corporate, person or firm is bound by virtue of or pursuant to any
statutory provision or any order of the Court made thereunder or otherwise to perform the said obligations; 

  

	 	9.4.4.	if the Company amalgamates or enters into any arrangement having the effect of amalgamation with any other body corporate, person or firm; or 

 

	 	9.4.5.	if the Company desires to be discharged of its duties as the Company and any other body corporate, person or firm enters into an agreement with the Trustee to perform the said obligations; 

then in any such event, (provided no breach of Section 128D of the Act results) by deed supplemental hereto in such form as the Company
and the Trustee require the Company shall be thereby released from all the said obligations, and such other body corporate, person or firm as aforesaid shall be deemed to be substituted for the Company as the person liable to perform the said
obligations, and the Deed and the Clog Letter shall henceforth have effect as if such other body corporate, person or firm had been a party to and had executed the Deed in place of the Company and as if the reference to the Company in the Deed were
references to such other body corporate, person or firm (save where the context requires otherwise). 
  

	10	APPOINTMENT AND REMOVAL OF TRUSTEE 

  

	10.1	The Company hereby declares and confirms the independence of the Trustee in the exercise of all of its functions and obligations under the Clog Program and undertakes that it shall not seek to influence the Trustee in
any matter. Notwithstanding the foregoing the Company will have the power (which may be exercised by resolution of the board of the Company or any committee of the board of the Company or by Deed) to remove such Trustee as Trustee of the Clog
Program and appoint a new or additional trustee in the place of the removed Trustee and in any other case where the office of the Trustee has been vacated, the Company may appoint a new trustee in place of the former Trustee. 

 PROVIDED ALWAYS that the power conferred by this Clause 10 shall only be operative and
capable of taking effect 42 days (or such other period as the Company and the Trustee may agree) from the date on which the first mentioned Trustee (if still in existence) receives notice in writing of such removal or replacement and the new trustee
accepts office as such new trustee which may be evidenced in each case by the relevant Trustee executing the deed removing or appointing him. 
  

	10.2	Any Trustee may, upon the expiry of 42 days’ (or such shorter period as the Company may allow) prior notice in writing given to the Company and the remaining Trustee (if any), resign as Trustee and thereupon cease
to be a Trustee and will not be responsible for any costs incurred by such retirement. 

  

	10.3	At all times throughout the Trust Period the Trustee shall comprise a single corporate Trustee: 

  

	 	(a)	which is established in an EEA Member State and the Trustee of which shall be resident in an EEA Member State; and 

  

	 	(b)	whose Memorandum of Association permits such company to exercise, and is not inconsistent with, the powers conferred on the Trustee under this Deed. 

 

	10.4	Except for the statutory power of the High Court to appoint a new or additional Trustee(s), the statutory power of appointing new or additional Trustee(s) shall not apply to the Trust. 

 

	10.5	An outgoing Trustee shall do all such acts or things and shall execute such documents or deeds as may be required or as may be necessary for vesting the Restricted Shares in the new Trustee or placing the Restricted
Shares under the control of the new Trustee and shall be bound and entitled to assume that any new Trustee is a fit and proper person to have been appointed in accordance with this Clause 10. 

PROVIDED THAT where an outgoing Trustee is liable as a Trustee for any duties or taxes then that Trustee shall not be required to
transfer the Restricted Shares unless reasonable security is provided for indemnifying the outgoing Trustee against such liability. 
  

	10.6	The Company hereby declares and confirms the independence of the Trustee and subject only to the express provisions to the contrary in the Clog Program or by applicable law, every power or discretion conferred on the
Trustee shall be an absolute and uncontrolled power or discretion and, save in cases of the Trustee’s or the Trustee Director’s fraud, wilful misconduct or gross negligence, neither the Trustee nor any Trustee Director shall be held liable
for any loss or damage occurring as a result of the Trustee concurring or refusing or failing to concur in an exercise or proposed exercise of such power or discretion and neither the Trustee nor any Trustee Director shall be obliged to give any
Participant (or any person who would, but for the exercise of any such power or discretion, be a Participant) any reason or justification for any exercise or non-exercise of any such power or discretion. 

 

	11	REMUNERATION OF TRUSTEE 

  

	11.1	The Trustee shall be entitled to be paid by the Company all professional or proper charges for work done by it in connection with the trusts declared in this Deed at the rates and otherwise on the terms agreed with the
Company, whether in the ordinary course of its business or not, including acts which a trustee, not being in any profession or business, could have done personally. 

 

	11.2	Subject to the approval of the Company, not to be unreasonably withheld or delayed, the Trustee may employ any banker, solicitor, stockbroker, auditor or investment advisor or other agent or professional adviser in
relation to the trusts declared in this Deed, any company, form or enterprise associated with it 

 PROVIDED THAT such
agent is authorised by its constitution to undertake such business and that is, in fact, ordinarily so engaged and that all charges made by it for work done or services provided in connection with the trusts declared in this Deed are reasonable and
normal. 
  

	11.3	The Trustee shall be entitled to be repaid or recompensed for such reasonable expenses as may be incurred in the performance of his duties as Trustee without being liable to account for same. The Company shall be liable
for the costs referred to in Clause 11.2 above. 

  

	12	CONFLICTS OF INTEREST 

  

	12.1	No decision of, or exercise of a power by, the Trustee shall be invalidated or questioned on the grounds that the Trustee or any individual Trustee Director has an interest in a personal or fiduciary capacity in the
result of any decision or in the exercising of any power 

 PROVIDED THAT where such interest arises other than from the employment of the Trustee or
individual Trustee Director by a Group Company, such interest shall have been disclosed to the Trustee except where the disclosure is being made by the Trustee itself and any such person shall have absented himself in the deliberations or vote in
respect thereof and shall not be taken into account for the purposes of a quorum. 
  

	12.2	Subject to compliance with the obligations in Chapter 5 of the Companies Act, 2014 (and, where appropriate, the Listing Rules of any stock exchange under which Shares or other securities of the Company may be regulated)
a Trustee Director shall not be precluded from acquiring, holding or dealing with any debentures, debenture stock, shares or securities whatsoever of the Company or any Subsidiary or from entering into any contract or other transaction with the
Company or such Subsidiary or being interested in any such contract or transaction and none of the Trustee Directors shall in any manner whatsoever be liable to account to the Company or Participants for any profits made or benefits obtained by them
thereby or in connection therewith. 

  

	13	COMPANY COVENANTS 

 The Company covenants with the Trustee to pay to the Trustee such
sums as pursuant to this Deed are required to be paid to the Trustee and to carry out, or procure to be carried out, such other covenants as pursuant to this Deed are required of the Company. 

 

	14	INFORMATION SUPPLIED BY THE COMPANY 

  

	14.1	The Trustee shall be entitled to rely and act on, without further enquiry, on all information supplied to it by the Company in connection with its duties as Trustee declared in this Deed and in particular, but without
prejudice to the generality of the foregoing, any notice given by the Company to the Trustee in respect of the eligibility of any person to become or remain a Participant shall be conclusive in favour of the Trustee’s determination.

  

	14.2	The Company shall supply the Trustee in writing with any information reasonably required by the Trustee for the purposes of the Trust. The Trustee may call for and shall be entitled and is hereby authorised to rely upon
and accept as sufficient evidence of any fact or matter (upon which the Trustee may in exercise of any of the trusts, powers and provisions vested in the Trustee under the Trust require to be satisfied or to have information) a notification or
certificate given on behalf of the Company as to any fact or matter prima facie within the knowledge of the Company, and the Trustee may rely and act upon any instruction received from the board or committee of the board of the Company as evidenced
by a copy of the appropriate resolution signed or purporting to be signed by the secretary or any director of the Company and the Trustee will in no way be bound to call for further evidence or be responsible for any loss that may be occasioned by
acting on such notification, certificate or instruction. 

  

	14.3	In particular, but without prejudice to the generality of the foregoing, any written statement signed by a person being of at least a managerial level in the personnel department of the Company, or such other person as
is notified to the Trustee from time to time by the Company, as to any circumstance affecting a person believed by the Trustee to be or not to be a Participant may be treated by the Trustee as conclusive evidence of the matters therein stated.

  

	14.4	Except as herein expressly provided, the Trustee will be and is hereby authorised to assume without enquiry in the absence of knowledge by or express notice to the Trusteeto the contrary that the Company is duly
performing and observing all the covenants and provisions contained in these presents to be performed and observed, and, notwithstanding any knowledge by or notice to the Trustee of any breach of covenant or obligation by the Company it will be in
the discretion of the Trustee whether to take any action or proceedings as to enforce the performance thereof, and in any case in which the Trustee decides to take any action or proceedings or to enforce the performance thereof the Trustee shall
first be indemnified to the Trustee’s satisfaction by the Company against all proceedings, claims and demands to which the Trustee may thereby become liable and all costs, charges, expenses and liabilities which may thereby be incurred.

	15	TRUSTEE’S LIABILITY 

  

	15.1	In the professed execution of the trusts and powers contained in this Deed: 

  

	 	(a)	save in cases of fraud, wilful misconduct or gross negligence by the Trustee, any Trustee Director or any of their respective agents or employees, the Trustee shall not be liable for any loss arising by reason of any
act, mistake or omission made by it; 

  

	 	(b)	save in cases of fraud, wilful misconduct or gross negligence by the Trustee Director himself, no Trustee Director shall be liable for any loss arising by reason of any act, mistake or omission by him or by reason of
any other matter or thing including fraud, negligence or default of another Trustee Director, agent, nominee, officer or other delegate or employee of the Trustee. 

 

	15.2	The Company hereby covenants with the Trustee and Trustee Directors that it will at all times keep them and their successors in title as Trustee or Trustee Directors (as the case may be) fully indemnified and held
harmless against all claims, losses, demands, actions, proceedings, charges, expenses, costs, damages, taxes, duties and other liabilities that may be suffered or incurred by it or them or by any of them in connection with the execution of the
trusts, powers and discretions vested in them by this Deed or otherwise arising howsoever out of or in connection with the preparation, administration of, operation or termination of the Deed other than liabilities arising as a consequence of the
Trustee’s or the Trustee Director’s own fraud, wilful misconduct or gross negligence (including in the case of the Trustee, that of its agents or employees). 

 

	15.3	In addition the Trustee will have the benefit of indemnities conferred on trustees generally by law. 

  

	15.4	The Trustee will not be liable to satisfy any monetary obligations under the Trust (including, but without prejudice to the generality of the foregoing, any monetary obligations to a Participant) beyond the sums of
money (including income (if any) arising from the investment thereof) from time to time in their hands or under their control as Trustee of the Trust and properly applicable for that purpose. 

 

	16	EFFECT OF THE CLOG PROGRAM 

  

	16.1	Any entitlement a Participant may have under this Trust is a matter entirely separate from any pension right or entitlement he/she may have and from his/her terms and conditions of service to the Company and it shall
not in any respect whatsoever affect in any way a Participant’s entitlements or terms and conditions of service. Without prejudice to the generality of the foregoing, the provisions of the Clog Program shall not form part of any contract of
services between any Participant and the Company and neither shall it be taken into account for the purpose of calculating any payment, settlement or award from or on behalf of the Company or any other Group Company to a Participant, including but
not limited to any redundancy or unfair dismissal payment or wrongful dismissal payment and it shall not confer on any Participant any legal or equitable rights whatsoever against the Company or any Group Company. 

 

	16.2	Any entitlements a Participant may have under the Clog Program shall have effect subject to the Articles so that in the event of any inconsistency or conflict between the provisions of this Deed, the Clog Letter and the
Articles, the provisions of the Articles shall prevail. 

  

	17	ARBITRATION 

  

	17.1	All disputes and differences arising out of the Clog Program or otherwise in connection therewith may be referred by the Company or Trustee to arbitration pursuant to the provisions of the Arbitration Act, 2010 and the
Company, the Trustee and any Participant so affected shall submit to arbitration. 

  

	18	TERMINATION 

  

	18.1	The Parties acknowledge and agree that the Trust shall be deemed to terminate on the date on which the Company has resolved to wind up the Clog Program and which the Company and the Trustee may by deed declare to be the
end of the Trust Period (the “Termination Date”). 

  

	18.2	For the avoidance of doubt the parties to the Clog Program agree and shall procure that the Termination Date shall not be a date earlier that the day after the last day of the Restricted Period applicable to any
Participant under the Clog Program. 

	19	INVALIDITY AND ENFORCEABILITY 

  

	19.1	It is the intention of the parties hereto that this Deed shall be enforceable to the fullest extent allowed by law. In the event that a court having jurisdiction holds any provision of this Deed to be invalid or
unenforceable, in whole or in part, the parties hereto agree that, if allowed by law, that provision shall be reduced to the degree necessary to render it valid and enforceable without affecting the rest of this Deed. 

 

	20	VARIATION 

  

	20.1	The terms of this Deed may be amended, revoked or extended by deed supplemental hereto executed by the Company and Trustee, provided, however, that no such amendment or variation may adversely affect any then existing
Participant without such Participant’s advance written consent. Any such amendment or variation will be binding on Participants but no amendments shall be made that will prevent the Restricted Shares according with Section 128D of the Act.

  

	21	DATA PROTECTION 

  

	21.1	The Trustee agrees that it will not use or disclose to third parties the Company’s data and the personal data of the Participants obtained in connection with the Clog Program, other than for the purpose of the Clog
Program. The Company agrees that the Trustee may disclose the Company’s data and the personal data of the Participants to its professional advisers, industry bodies, regulatory and other authorities and insurers, amongst others, in connection
with these purposes. The Company agrees to keep the Trustee updated of any changes to the Company’s data and the personal data of the Participants. 

  

	21.2	The Company has the right to access the Company’s data and the personal data of the Participants held about the Company and/or the Participants by the Trustee at any time by sending a written request to the
Trustee. The Company also has the right to require the Trustee to correct any inaccuracies in such information. 

  

	22	NOTICES AND CONSENTS 

  

	22.1	Unless the Trustee, the Company and the Participant shall, in each case, otherwise agree any notices and consents required or permitted to be given: 

 

	 	(a)	to the Trustee shall be sent in writing (i) by post or by hand delivery to the address set out for the Trustee in this Deed or to such other address as the Trustee may notify to the Company; (ii) via email to
the email address notified to the Company from time to time and the Company hereby undertakes to notify the Trustee promptly of any change of address or email address of the Company; or (iii) by facsimile to a designated number which will be
notified to the Company from time to time. 

  

	 	(b)	to the Company shall be sent in writing (i) by post or hand delivery to the address set out for the Company in this Deed or such other addresses as the Company may notify to the Trustee; (ii) via email to the
email address notified to the Trustee from time to time and the Company hereby undertakes to notify the Trustee promptly of any change of address or email address of the Company; or (iii) by facsimile to a designated number which will be
notified to the Trustee from time to time. 

  

	 	(c)	to the Participant shall be sent in writing (i) by post or hand delivery to the address set out for the Participant in the Clog Letter or such other addresses as the Participant may notify to the Trustee;
(ii) via email to the email address notified to the Trustee from time to time and the Participant hereby undertakes to notify the Trustee promptly of any change of address or email address of the Participant; or (iii) by facsimile to a
designated number which will be notified to the Trustee from time to time. 

  

	22.2	Notices and consents shall be deemed to have been served forty eight (48) hours after despatch and in proving service of notice to the Company it shall be sufficient to show that such notice was placed in an
envelope addressed to the Company at the address set out above (or such address notified in accordance with this Clause 22) and despatched by pre-paid post or hand delivery. Any such matter sent by email shall be deemed to have been delivered at the
time of receipt of the email. Any such matter sent by facsimile shall be deemed to have been served once a successful facsimile transmission report has issued to the transmitter. All notices or other documentation sent by the Trustee to the Company
are sent at the Company’s own risk. 

  

	23	STAMP DUTY 

  

	23.1	Any stamp duty or other expenses involved in any transfer of Restricted Shares by the Trustee shall be payable: 

  

	 	(a)	in the case of a transfer by the Trustee into the name of the Participant concerned, by the Participant; and 

	 	(b)	in any other case, by the transferee concerned. 

  

	24	COUNTERPARTS 

  

	24.1	This Deed may be executed in any number of counterparts and by the different parties hereto on separate counterparts each of which when executed and delivered shall constitute an original all such counterparts together
constituting one and the same instrument, but shall not be effective until each party has executed at least one counterpart. 

  

	25	GOVERNING LAW 

  

	25.1	This Deed and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the laws
of Ireland. 

  

	26	JURISDICTION 

  

	26.1	Each party irrevocably agrees that the courts of Ireland shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this deed or its subject matter or formation (including
non-contractual disputes or claims). 

  

	26.2	Each party irrevocably consents to any process in any legal action or proceedings under Clause 26.1 being served on it in accordance with the provisions of this deed relating to service of notices. Nothing contained in
this deed shall affect the right to serve process in any other manner permitted by law. 

 IN WITNESS whereof this Deed
was executed the day and year first above written. 

 GIVEN under the Common Seal of 

Horizon Pharma Public Limited 
 Company and this DEED has
been 
 DELIVERED: 
  

	
	 /s/ Timothy P. Walbert

	Director
	 /s/ David G. Kelly

	Director/Secretary

 GIVEN under the Common Seal of 

Goodbody Trustees Limited 
 and this DEED has been 

DELIVERED: 
  

	
	 /s/ illegible

	Director
	 /s/ illegible

	Director/Secretary

 

 
 [            ] 

CLOG LETTER 

[            ] 

c/o Horizon Pharma plc 
 Connaught House 

1 Burlington Road 
 Dublin 4 

Re: Clog Letter in respect of an award of RSUs which may vest in accordance with the terms of the Company’s 2014 Non-Employee Equity Plan (the Plan)
on [            ] 
 Dear
[            ], 
 This letter applies to a maximum of
[            ] shares in Horizon Pharma plc (the Company) which may vest to you on [            ] in accordance with the
Plan. 
 You are required to contractually agree to retain such vested shares in Horizon Pharma plc (the Shares) for the specified period of
[            ] (the Restricted Period). During the Restricted Period Goodbody Trustees Limited (the Trustee) will hold the legal title to the Shares and will retain the share
certificate relevant to the Shares pursuant to the terms of a Deed of Trust executed between the Trustee and the Company on 18 September 2015. During the Restricted Period the Shares will be subject to the Retention Condition (commonly known as
a “Clog”) set out in the next paragraph. Please note that the precise number of Shares vesting to you and the Restricted Period will be advised to you on the relevant vesting date of the Shares. The Restricted Period will commence on
the date the award of RSUs vests in accordance with the provisions of the Plan and will apply to the Shares issuable or transferable to you at vesting. 

Retention Condition attached to the Shares 
 You shall not
assign, charge, pledge as security for a loan or other debt, transfer or otherwise dispose of all or any interest in the Shares in any circumstances during the Restricted Period. 

You agree that the Trustee and the Company shall be entitled to treat any attempt to assign, charge, pledge as security for a loan or other debt, transfer or
otherwise dispose of all or any interest in the Shares during the Restricted Period, other than where permitted under the Exceptions to the Retention Condition as set out below as null and void. 

Please note that by executing and returning the Acceptance Form set out in Schedule 1 to this Letter to the Company you are consenting to and agree to be
bound by the Retention Condition which will inhibit your freedom to deal with or realise value from the Shares during the Restricted Period. Please note that your agreement and consent to be bound by the Retention Condition may cause financial loss
for which the Company does accept any responsibility. 
 Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, Ireland 

www.horizonpharma.com 
 Horizon Pharma
Public Limited Company Registered in Ireland No, 507678 
 T: +353 (0) 1 772 2100 | F: +353 (0) 1 772 2101 

Registered Office: Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, Ireland 

Directors: T. Walbert {U.S.}, M. Grey {U.S./UK}, L Daniel {IRE}, J. Himawan {U.S.}, V. Nohria {UK}, R. Pauli {U.S.}, G. Santini {U.S./IT}, T. Watkins {U.S.}

 

 
  

 Exceptions to the Retention Condition 

Notwithstanding that you are bound to adhere to the Retention Condition during the Retricted Period you may transfer, assign, charge, pledge as security for a
loan or other debt, or otherwise dispose of the Shares in accordance with Section 128D(3)(c) of the Taxes Consolidation Act, 1997 as amended (the Act) which are on the occurrence of the following events: 

upon your death, or 
 as a consequence of you agreeing to 

accept an offer for the Shares if the acceptance or agreement would result in a new holding (within the meaning of section 584 of the Act)
being equated with the Shares for the purposes of capital gains tax, 
 a transaction affecting the Shares or such number of the Shares as
are of a particular class if the transaction would be entered into pursuant to a compromise, arrangement or scheme applicable to or affecting all the ordinary share capital of Horizon Pharma plc or, as the case may be, all the shares of the same
class as the Shares acquired by you, or 
 accept an offer of cash, with or without other assets, for the Shares if the offer forms part of a
general offer made to holders of shares of the same class as the Shares acquired by you or of shares in the same company and made in the first instance on a condition such that if it is satisfied the person making the offer will have control (within
the meaning of section 432 of the Act) of that company. 
 Compulsory Acquisition 

It should be noted that if an offer were to be made to acquire the entire issued share capital of the Company, the offeror can, subject to receiving the
specified level of acceptances, compulsorily acquire the shares held by those persons who do not accept the offer. If this were to happen, the restriction on disposal of the Shares during the Restricted Period cannot prevent a compulsory acquisition
of the Shares. Should the Shares subject to the Restricted Period be disposed of in such circumstances some of the tax relief afforded will be clawed back and due for payment to the Revenue Commissioners. 

Taxation 
 Ireland 

The vesting of RSUs will give rise to a gain that is subject to income tax, the Universal Social Charge (USC) and Social Security (if applicable) at your
marginal rates. Acceptance of the terms set out in this letter will result in a reduction in the amount of this gain that will be subject to income tax, USC and Social Security (if applicable) but it will not result in the deferral of the resultant
tax and Social Security liabilities. The Company is obliged to collect the income tax (PAYE), USC and employee Social Security (if applicable) due by you through payroll deductions via the PAYE system. You may also have tax filing obligations under
the self assessment system of “pay and file”. 
 It is your responsibility to seek taxation advice relevant to your particular circumstances. The
Company accepts no responsibility to provide you with such tax advice or for any tax consequences for you for being awarded the Shares. 
 Normally, the
taxable amount of the gain arising on the award of shares will equal the difference between the market value of the shares acquired less any amount paid. However, under Section 128D of the Act, the taxable amount is reduced by
[            ]% of the market value of the shares where the Restricted Period is for a period of [            ]. 

Miscellaneous 
 This Letter constitutes the entire
agreement between you and the Company and supersedes and extinguishes all previous agreements, promises, assurances, warranties, representations and understandings between you and the Company, whether written or oral, relating to the Shares. 

This Letter and the Acceptance Form contained in Schedule 1 to this Letter shall be governed by and construed in accordance with Irish law. 

  
 2 

 

 
  

 Acknowledgement and Consent 

By returning the Acceptance Form you signify your acceptance of the arrangement in respect of the Shares issuable or transferable to you on vesting of the
Restricted Stock Units under the Plan and the Retention Condition applicable to the Shares during the Restricted Period. 
 Please return the completed
Acceptance Form to the Company on or before [            ]. 
  

	
	Signed
by:                                        
                     
	On behalf of (the Company)
	
	Date:

  
 3 

 

 
  

 SCHEDULE 1 

Acceptance Form 
  

			
	To:	  	Horizon Pharma plc
		  	Connaught House
		  	1 Burlington Road
		  	Dublin 4
		
	To:	  	Goodbody Trustees Limited
		  	IFSC
		  	15-28 North Wall Quay
		  	Dublin 1

 I, [            ], hereby absolutely, irrevocably and
unconditionally 
  

	(i)	acknowledge and accept the terms outlined in the Clog Letter dated [            ] concerning the Shares which may be issuable or transferable to me on
[            ] on the vesting of my RSU award and agree to be bound by its terms including this Acceptance Form and the trust deed relating to the trust in which my Shares will be held for
the Restricted Period; and 

  

	(ii)	agree to be bound by the Retention Condition applicable to the Shares during the Restricted Period which will cease on [            ]. 

 

	(iii)	agree that in the absence of any other direction from me, on a rights issue by the Company during the Restricted Period, I hereby direct the Trustee to sell sufficient of my rights to enable the Trustee to finance the
subscription of the balance; 

  

	(iv)	agree that in the absence of any other direction from me, in the event of a general offer to acquire the shares of the Company or another offer for such share capital affecting the Shares during the Restricted Period, I
hereby direct the Trustee to accept such offer. 

  

	(v)	agree that the Company and/or the Trustee may send communications regarding my Shares in hard copy and/or by way of electronic communications and that communications and information may be delivered to me by providing
me with details of where I can access the same on a website or intranet site. 

  

	(vi)	agree that I will provide the Company with such information as may be required from time to lime by the Company or the Trustees for the effective operation of the Restricted Share Plan, including any record keeping and
tax reporting obligations that may arise. For the avoidance of doubt such information may include, but is not limited to, the following: current address, marital/civil partnership status, tax residency status, citizenship and information as to your
legal capacity. I undertake to inform the Company and the Trustee should any such information previously provided by you change. 

 Data
Protection 
 By signing this Acceptance Form you consent to the collection, holding, processing and transfer of personal data to, by and between the
Company, Trustee and any other party (the Entities) for all purposes in connection with the Plan and the Horizon Pharma plc Director Share Clog Program. Such personal data may be held by the Entities and retained after the end of the Restricted
Period. 
 You acknowledge that this may involve the transfer of personal data outside Ireland to countries outside the European Economic Area where further
processing of the data for the purposes outlined above may occur. You acknowledge that countries outside the European Economic Area may not have the same data protection laws and safeguards as are in operation in Ireland. 

For the purpose of this consent to the transfer and disclosure of personal data the data involved may include, but is not limited to: name, address, telephone
and fax numbers, e-mail addresses, gender, emergency contact, employee number, PPS number, wage and bonus information, participation levels, personal bank account number and tax related information. 

You note that you have a reasonable right of access to the personal data that the Entities hold about you and that you can request access to this data and
rectify this data (if necessary) via the Company’s HR department. You acknowledge that the processing and transfer of your personal data is necessary for the administration of the Restricted Share Plan. 

  
 4 

 

 
  

 Terms defined in this Acceptance Form shall, unless the context otherwise requires, have the same meaning as
in the Clog Letter or, if not so defined, in the trust deed relating to the Restricted Share Plan. 
  

							
	Signature:                                    
                                         
                        	 		 		 	Date
:                                         
                                         
                            
	PPS Number:                                   
                                         
                    	 		 		 	

  
 5 

 Dated 22nd day of February 2016 

HORIZON PHARMA PUBLIC LIMITED COMPANY 

One Part 
 GOODBODY TRUSTEES
LIMITED 
 Second Part 

DEED OF AMENDMENT 
 to
the 
 HORIZON PHARMA PUBLIC LIMITED COMPANY DIRECTOR SHARE CLOG PROGRAM 

A & L Goodbody 
 25-28 North
Wall Quay 
 IFSC 
 Dublin 1

 THIS DEED OF AMENDMENT made the 22nd day of February,
2016 
 BETWEEN: 
 HORIZON PHARMA PUBLIC
LIMITED COMPANY, a company incorporated in Ireland and whose registered office is at Connaught House, 1st floor, 1 Burlington Road, Dublin 4 (the Company) of the first part; and 

GOODBODY TRUSTEES LIMITED, a company incorporated in Ireland and whose registered office is at IFSC, 25-28 North Wall Quay, Dublin 1 (the
Trustee) of the second part. 
 IS SUPPLEMENTAL TO: 

A Trust Deed dated 18 September 2015 (the Principal Deed) between the Company and the Trustee establishing the Horizon Pharma Public Limited
Company Director Share Clog Program (the Clog Program). 
 WHEREAS: - 

 

	A.	Clause 20 of the Principal Deed permits the Company and the Trustee to alter by supplemental deed any provisions of the Principal Deed as therein set out. 

 

	B.	The Company (with the consent of the Trustee as is testified by their execution of this Deed) wishes to amend the Principal Deed as hereinafter set out. 

NOW THIS DEED WITNESSES and it is hereby agreed as follows:- 
  

	1.	The word “Director” shall be deleted from the name of the Clog Program, which from the date of this Deed shall be known as the Horizon Pharma Public Limited Company Share Clog Program. 

 

	2.	Recital A of the Principal Deed shall be deleted and replaced with the following: 

 “The
Company has granted equity awards with respect to its Shares (as defined below) to employees and non-employee directors under the terms of the Company’s equity incentive plans.” 

 

	3.	Recital B of the Principal Deed shall be deleted and replaced with the following: 

 “By
entry into the Clog Letter and into this Deed (together being, and hereinafter referred to as, the “Clog Program”) the Company now wishes to impose a restriction on the manner in which the Restricted Shares (as defined below)
acquired by Participants in connection with the grant, vesting, exercise or settlement, as the case may be, of their awards granted under the Company’s equity incentive plans, can be dealt with by the Participants for the duration of the
Restricted Period (as defined below).” 
  

	4.	The definition of Acquisition Date shall be deleted and replaced with the following: 

  

			
	“Acquisition Date	 	 the date on which Restricted Shares are acquired by the Trustee on behalf of a Participant pursuant to the Clog Program
being the date or dates the Restricted Shares are issued in settlement of the Participant’s award under the terms of one of the Company’s equity incentive plans;”

  

	5.	The definition of Participant shall be deleted and replaced with the following: 

  

			
	“Participant	 	 means an employee or director of a Group Company who has elected to participate in the Clog Program including, where
the context so permits, the legal personal representatives of a deceased Participant as evidenced to the Trustee by a grant or probate or letters of administration;”

	6.	The definition of Restricted Shares shall be deleted and replaced with the following: 

  

			
	“Restricted Shares	 	 means the Shares which the Participant agrees are subject to the Clog Program, as specified in the Clog
Letter;”

  

	7	The definition of Shares shall be deleted and replaced with the following: 

  

			
	“Shares	 	 the ordinary shares of US$0.0001 each in the capital of the Company issuable or transferable to each Participant under
the terms of equity awards granted under one of the Company’s equity incentive plans, which expression shall include (i) any additional or substituted securities derived from or distributed in respect of such shares after the date hereof
including, without limitation, by virtue of a bonus issue or capitalisation, scrip issue, subdivision, re-organisation, consolidation or other alteration in the capital structure of the Company or the purchase of shares pursuant to any pre-emption
rights and/or the proceeds of any redemption or purchase of such shares; and (ii) such further ordinary shares of US$0.0001 each in the capital of the Company that the Trustee holds subject to the terms of this Deed;”

  

	8.	The words “obtained in connection with an RSU” shall be deleted from clause 3.1. 

  

	9.	Clause 4.2 shall be deleted and replaced with the following: 

 “On the acquisition of
Shares in connection with the grant, vesting, exercise or settlement (as the case may be) of an equity award granted under one of the Company’s equity incentive plans where some or all of the Shares subject to that award have been designated as
Restricted Shares, the Company shall allot and issue, or transfer, the Restricted Shares issuable or transferable to the relevant Participant in connection therewith in the name of (or in accordance with the directions of) the Trustee and write up
the Company’s register of members accordingly.” 
  

	10.	Clause 16.1 shall be deleted and replaced with the following: 

 “Any entitlement a
Participant may have under this Trust is a matter entirely separate from any pension right or entitlement he/she may have and from his/her terms and conditions of service to or employment with any Group Company and it shall not in any respect
whatsoever affect in any way a Participant’s entitlements or terms and conditions of service or employment. Without prejudice to the generality of the foregoing, the provisions of the Clog Program shall not form part of any contract of services
or employment between a Participant and any Group Company and neither shall it be taken into account for the purpose of calculating any payment, settlement or award from or on behalf of the Company or any other Group Company to a Participant,
including but not limited to any redundancy or unfair dismissal payment or wrongful dismissal payment and it shall not confer on any Participant any legal or equitable rights whatsoever against the Company or any Group Company. 

 

	11.	Unless the context otherwise admits or requires all capitalised terms in this Deed shall have the same meaning as in the Principal Deed. 

 

	12.	This Deed may be executed in more than one counterpart, and by the parties to it on separate counterparts, but shall not be effective until each party has executed at least one counterpart, with the same effect as if
the parties to this Deed executing in the several counterparts had all executed one document. 

  

	13.	This Deed shall be governed by and construed in accordance with the law of the Republic of Ireland. 

 IN WITNESS whereof this Deed has been duly executed by the parties hereto the day and year first above
written. 
 GIVEN under the Common Seal of 
 HORIZON PHARMA
PUBLIC LIMITED COMPANY 
  

	
	 /s/ Liam Daniel

	Director
	
	 /s/ David Kelly

	Director/Secretary

 GIVEN under the Common Seal of 

GOODBODY TRUSTEES LIMITED 
  

	
	 /s/ James Somerville

	Director
	
	 /s/ James Grennan

	Director/Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]